Yamaya Corporation (TYO:9994)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	28,892	30,909	35,127	28,264	26,996	26,606
Market Cap Growth	-12.01%	-12.01%	24.28%	4.70%	1.47%	21.91%
Enterprise Value	25,184	24,262	30,163	25,799	25,799	27,696
Last Close Price	2665.00	2851.00	3181.57	2516.93	2356.66	2276.98
PE Ratio	7.93	8.48	9.71	14.65	6.13	-
PS Ratio	0.18	0.19	0.22	0.19	0.19	0.18
PB Ratio	0.77	0.83	1.05	0.96	0.93	1.09
P/TBV Ratio	0.85	0.91	1.15	1.06	1.07	1.25
P/FCF Ratio	27.67	29.61	7.78	15.12	7.97	-
P/OCF Ratio	10.29	11.01	6.45	9.16	6.08	-
EV/Sales Ratio	0.16	0.15	0.19	0.17	0.18	0.19
EV/EBITDA Ratio	3.75	3.63	3.98	6.19	12.61	16.59
EV/EBIT Ratio	4.61	4.47	4.77	9.09	40.06	-
EV/FCF Ratio	24.12	23.24	6.68	13.80	7.62	-
Debt / Equity Ratio	0.18	0.18	0.24	0.34	0.46	0.48
Debt / EBITDA Ratio	1.02	1.02	1.07	2.43	6.58	7.03
Debt / FCF Ratio	6.52	6.52	1.79	5.42	3.97	-
Asset Turnover	2.48	2.48	2.64	2.54	2.42	2.48
Inventory Turnover	5.43	5.43	6.17	6.59	6.83	7.11
Quick Ratio	0.84	0.84	0.85	0.72	0.72	0.48
Current Ratio	1.94	1.94	1.80	1.59	1.52	1.16
Return on Equity (ROE)	12.75%	12.75%	13.12%	3.98%	20.33%	-40.01%
Return on Assets (ROA)	5.24%	5.24%	6.49%	2.95%	0.68%	-0.26%
Return on Capital (ROIC)	7.91%	7.91%	9.71%	4.31%	1.02%	-0.39%
Return on Capital Employed (ROCE)	12.20%	12.20%	15.70%	7.80%	1.80%	-
Earnings Yield	12.61%	11.79%	10.30%	6.83%	16.30%	-29.99%
FCF Yield	3.61%	3.38%	12.85%	6.61%	12.55%	-6.07%
Dividend Yield	2.66%	1.89%	1.70%	2.07%	2.12%	2.20%
Payout Ratio	16.36%	16.36%	15.57%	29.17%	12.31%	-
Buyback Yield / Dilution	-	-	-	-	-	0.01%
Total Shareholder Return	2.66%	1.89%	1.70%	2.07%	2.12%	2.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.